-
公开(公告)号:US20210238539A1
公开(公告)日:2021-08-05
申请号:US17050626
申请日:2019-05-21
Applicant: DSM IP Assets B.V.
Inventor: Christopher Mark FARRELL , Lisa Ann LAPRADE , Otto Martin LEHMANN , Joshua TRUEHEART , Bastien Jean Wolfgang CHEVREUX
Abstract: The present invention is related to an improved method for production of 7-dehydrocholesterol (7-DHC), an important intermediate towards biotechnological production of vitamin D3 or derivatives/metabolites thereof. The invention features modified yeast strains expressing enzymes having improved C-8 sterol isomerase activity leading to increased ratios of 7-DHC in the sterol mix.
-
公开(公告)号:US20210222222A1
公开(公告)日:2021-07-22
申请号:US17051610
申请日:2019-05-21
Applicant: DSM IP ASSETS B.V.
Inventor: Christopher Mark FARRELL , Lisa Ann LAPRADE , Otto Martin LEHMANN , Joshua TRUEHEART , Bastien Jean Wolfgang CHEVREUX
Abstract: The present invention is related to an improved method for production of 7-dehydrocholesterol (7-DHC), an important intermediate towards biotechnological production of vitamin D3 or derivatives/metabolites thereof. The invention features modified host strains expressing enzymes having improved C-5 sterol 5 desaturase activity and their use in a process for production of vitamin D3 or derivatives and/or metabolites thereof.
-
公开(公告)号:US20210115412A1
公开(公告)日:2021-04-22
申请号:US17050603
申请日:2019-05-21
Applicant: DSM IP ASSETS B.V.
Inventor: Christopher Mark FARRELL , Lisa Ann LAPRADE , Otto Martin LEHMANN , Joshua TRUEHEART
Abstract: The present invention is related to modified sterol acyltransferase enzymes with improved activity and/or specificity towards acylation of the vitamin D3 precursor 7-dehydrocholesterol (7-DHC) to be used in biotechnological production of vitamin D3. The invention further relates to a yeast strain expressing said modified enzymes and their use in a process for production of vitamin D3 or derivatives and/or metabolites thereof.
-
公开(公告)号:US20240279706A1
公开(公告)日:2024-08-22
申请号:US18292227
申请日:2021-07-27
Applicant: DSM IP ASSETS B.V.
Inventor: Peter Louis HOUSTON , Valmik Kanubhai VYAS , Anna SYMBOR-NAGRABSKA , Reed Chadbourne DOTEN , Christopher Mark FARRELL , Ethan LAM
CPC classification number: C12P23/00 , C12N1/16 , C12N9/1029
Abstract: The present invention is related to a novel process for production of retinyl acetate in a host cell, particularly oleaginous yeast such as e.g. Yarrowia, wherein the product purity could be increased with reduction of unwanted side-products. Particularly, the novel process comprises fermentation in the presence of ethanol, such as e.g. in a fed-batch fermentation process. Such process is especially useful in a biotechnological process for production of vitamin A.
-
公开(公告)号:US20220010291A1
公开(公告)日:2022-01-13
申请号:US17293800
申请日:2019-11-11
Applicant: DSM IP ASSETS B.V.
Abstract: The present invention is related to an improved process for production of vitamin B2 using a genetically engineered host cell comprising a heterologous enzyme with pyridoxal phosphatase activity. Using said modified host cell, the yield of riboflavin production could be increased by at least about 5%.
-
-
-
-